Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Sonoma Pharmaceuticals specializes in developing and manufacturing stabilized hypochlorous acid (HOCl) products for healthcare and disinfection. Its core segments include wound care, dermatology, eye, oral, nasal, podiatry, animal health, and surface disinfectants. The company markets globally through direct sales and partnerships, emphasizing safe, effective, and cost-efficient solutions backed by extensive regulatory approvals and proprietary technology.
This description was generated via AI from an annual report. Updated about 1 year ago.